A study reported that TNF-NFKB1 signaling can directly regulate CD47 by interacting with a constituent enhancer located within a CD47-associated super-enhancer specific to breast cancer (Liu et al., 2018). The gene discussed is NFKB1; the disease is breast carcinoma.